These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4220782)

  • 21. [Proteolytic enzymes in leukocytes].
    Frydecka I
    Acta Haematol Pol; 1974; 5(1):73-7. PubMed ID: 4595061
    [No Abstract]   [Full Text] [Related]  

  • 22. Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man.
    Gans H; Subramanian V; John S; Castaneda AR; Lillehei CW
    Ann N Y Acad Sci; 1968 Jun; 146(2):721-36. PubMed ID: 4239441
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of cytostatic agents on fibrinolytic and proteolytic enzymes and on phagocytosis of guinea pig leucocytes.
    Prokopowicz J; Rejniak L; Niewiarowski S
    Experientia; 1967 Oct; 23(10):813-4. PubMed ID: 6076304
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.
    Spöttl F; Holzknecht F
    Thromb Diath Haemorrh; 1970 Oct; 24(1):101-12. PubMed ID: 4249466
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimation of proteolytic enzymes by means of their fibrinolytic activity.
    ASTRUP T; ALKJAERSIG N
    Arch Biochem Biophys; 1952 May; 37(1):99-105. PubMed ID: 14953418
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood coagulating properties of immobilized proteases].
    Zubairov DM; Zinkevich OD
    Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for studying fibrinolytic pathway components in human plasma.
    Wohl RC; Sinio L; Robbins KC
    Thromb Res; 1982 Sep; 27(5):523-35. PubMed ID: 6217585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of proteolytic activity on the isolation and stability of platelet proteins.
    Ganguly P
    Clin Chim Acta; 1969 Sep; 25(3):371-8. PubMed ID: 4241713
    [No Abstract]   [Full Text] [Related]  

  • 30. Measurement of proteolytic activity of leukoblasts--a new diagnostic method.
    Kirchmayer S; Stalowa I; Biernacka B; Slizowska H
    Pol Arch Med Wewn; 1970; 4(4):365-8. PubMed ID: 5464912
    [No Abstract]   [Full Text] [Related]  

  • 31. Lactones as inhibitors of the fibrinolytic system.
    Auerswald W; Doleschel W
    Science; 1967 Jun; 156(3779):1244-5. PubMed ID: 4225897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
    López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
    Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The leucocyte proteolytic properties as an diagnostic aid in differentiation of leukemias.
    Gonciarz Z; Koźmiński R; Wilk M; Rybicka J
    Pol Arch Med Wewn; 1970; 4(4):385-8. PubMed ID: 5270622
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular events responsible for modulation of neoantigenic expression: the cleavage-associated neoantigen of fibrinogen (blood coagulation-fibrinogen cleavage products-fibrinolysis-molecular conformation).
    Plow E; Edgington TS
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):208-12. PubMed ID: 4109598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease content and fibrinolytic activity of human leukocytes.
    Astrup T; Henrichsen J; Kwaan HC
    Blood; 1967 Jan; 29(1):134-8. PubMed ID: 6017604
    [No Abstract]   [Full Text] [Related]  

  • 36. Alterations in fibrinogen, plasminogen, and inhibitors of plasmin with the growth of V2 carcinoma in rabbits.
    Mootse G; Agostino D; Cliffton EE
    J Natl Cancer Inst; 1965 Sep; 35(3):567-72. PubMed ID: 4220790
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinolytic and proteolytic activity in acute and chronic leukemia.
    Girolami A; Cliffton EE
    Am J Med Sci; 1966 Jun; 251(6):638-45. PubMed ID: 4223510
    [No Abstract]   [Full Text] [Related]  

  • 38. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
    Beller FK; Maki M
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):114-32. PubMed ID: 4229208
    [No Abstract]   [Full Text] [Related]  

  • 39. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on human platelet protease activity.
    Nachman RL; Ferris B
    J Clin Invest; 1969 Nov; 47(11):2530-40. PubMed ID: 4237782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.